REDUCED EXPRESSION OF INTERLEUKIN-2 RECEPTORS IN HYPOGAMMAGLOBULINAEMIA: A POSSIBLE CAUSE OF HIGHER CANCER INCIDENCE
- 21 June 1986
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 327 (8495) , 1442-1443
- https://doi.org/10.1016/s0140-6736(86)91586-2
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- ISOLATION OF RETROVIRUSES FROM TWO PATIENTS WITH "COMMON VARIABLE" HYPOGAMMAGLOBULINAEMIAThe Lancet, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- IMPAIRED LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY IN PATIENTS WITH HYPOGAMMAGLOBULINAEMIAThe Lancet, 1985
- Partial restoration of impaired interleukin-2 production and Tac antigen (putative interleukin-2 receptor) expression in patients with acquired immune deficiency syndrome by isoprinosine treatment in vitro.Journal of Clinical Investigation, 1985
- Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2Science, 1984
- A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptorNature, 1982